Scholars Central

Research articlePublished 2020

Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial

Authors: Muhammad Sayuti, Ignatius Riwanto, B. Parish Boediono, Teuku Ilhami Surya Akbar

Systematic Reviews in Pharmacy

Volume 11 · Issue 10 · Pages 313–317

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Phyllanthus niruri Linn (PNL) is a folk medicine that believed to exhibit anticancer effect. Granzyme, one of serine proteases produced by cytotoxic-T-lymphocytes (CTL) and natural killer cells (NK cells), is suggested as a prognostic marker of cancer. This study aimed to assess the effect of PNL extract on colorectal cancer cells growth by measuring granzyme expression. An experimental study utilized pre- and post-treatment design was conducted in Dr. Kariadi General Hospital, Semarang, Indonesia from May to July 2016. Hospitalized colorectal cancer patients were administrated with daily oral PNL extract for 14 days. Granzyme expressions before and post-treatment were measured using immunohistochemical staining technique. The difference of granzyme expression was analyzed using paired t-test. Fifteen patients with colorectal cancer were enrolled in this study. The mean granzyme expression of pre- and post-treatment was 25.46%±4.82% and 65.71%±7.91%, respectively. There was a significant increase of granzyme expression in post-treatment compared to pre-treatment group, p<0.001. In conclusion, PNL extract increased granzyme expression on colorectal cancer patients, suggesting its role as anticancer agent. How to Cite this Article Pubmed Style Sayuti M, Riwanto I, Boediono BP, Akbar TIS. Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. SRP. 2020; 11(10): 313-317. doi:10.31838/srp.2020.10.52 Web Style Sayuti M, Riwanto I, Boediono BP, Akbar TIS. Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. http://www.sysrevpharm.org/?mno=27083 [Access: March 29, 2021]. doi:10.31838/srp.2020.10.52 AMA (American Medical Association) Style Sayuti M, Riwanto I, Boediono BP, Akbar TIS. Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. SRP. 2020; 11(10): 313-317. doi:10.31838/srp.2020.10.52 Vancouver/ICMJE Style Sayuti M, Riwanto I, Boediono BP, Akbar TIS. Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. SRP. (2020), [cited March 29, 2021]; 11(10): 313-317. doi:10.31838/srp.2020.10.52 Harvard Style Sayuti, M., Riwanto, . I., Boediono, . B. P. & Akbar, . T. I. S. (2020) Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. SRP, 11 (10), 313-317. doi:10.31838/srp.2020.10.52 Turabian Style Sayuti, Muhammad, Ignatius Riwanto, B. Parish Boediono, and Teuku Ilhami Surya Akbar. 2020. Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. Systematic Reviews in Pharmacy, 11 (10), 313-317. doi:10.31838/srp.2020.10.52 Chicago Style Sayuti, Muhammad, Ignatius Riwanto, B. Parish Boediono, and Teuku Ilhami Surya Akbar. "Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial." Systematic Reviews in Pharmacy 11 (2020), 313-317. doi:10.31838/srp.2020.10.52 MLA (The Modern Language Association) Style Sayuti, Muhammad, Ignatius Riwanto, B. Parish Boediono, and Teuku Ilhami Surya Akbar. "Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial." Systematic Reviews in Pharmacy 11.10 (2020), 313-317. Print. doi:10.31838/srp.2020.10.52 APA (American Psychological Association) Style Sayuti, M., Riwanto, . I., Boediono, . B. P. & Akbar, . T. I. S. (2020) Anticancer Activity of Phyllanthus Niruri Linn Extract in Colorectal Cancer Patients: A phase II Clinical Trial. Systematic Reviews in Pharmacy, 11 (10), 313-317. doi:10.31838/srp.2020.10.52

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Muhammad Sayuti”
  • BylineArticles whose byline prints “Ignatius Riwanto”
  • BylineArticles whose byline prints “B. Parish Boediono”
  • BylineArticles whose byline prints “Teuku Ilhami Surya Akbar”